H.R. 733: Recalcitrant Cancer Research Act of 2012

112th Congress · introduced 2011-02-16 · Health · Latest: Received in the Senate.

federal

Follow this bill, step by step

Where it came from: introduced 2011-02-16 · official record
Who proposed it: Rep. Eshoo, Anna G. [D-CA-14] · what a sponsor is
What happened next: no floor votes in our records yet. Why?
Where it stands now: Received in the Senate. Not final yet: this can still change. We check for updates every day.
If it becomes law and spends money: follow the money to money laws, then agencies and contracts and grants.

What does this mean?

Official title

Recalcitrant Cancer Research Act of 2012

Plain summary

Recalcitrant Cancer Research Act of 2012 - Amends the Public Health Service Act to require the Director of the National Cancer Institute (NCI) to develop a scientific framework for research on recalcitrant cancers (cancer with a 5-year relative survival rate below 50%), which includes: (1) a review of the status of research, such as a summary of findings, identification of promising scientific advances, a description of the availability of qualified scientific researchers, and the identification of resources available to facilitate research; (2) identification of research questions that have not been adequately addressed; and (3) recommendations for actions to advance research and for appropriate benchmarks to measure progress on achieving such actions. Requires the Director to develop the framework within 18 months and review and update it every 5 years. Requires the Director to identify within 6 months 2 or more recalcitrant cancers that have a 5-year relative survival rate of less than 20%, and are estimated to cause the death of at least 30,000 individuals in the United States per year. Authorizes the Director to identify additional such cancers and to consider additional metrics of progress (such as incidence and mortality rates) against such cancer. Requires the Director to convene a working group for each identified cancer to provide expertise on, and assist in developing, a scientific framework under this Act. Requires the Director to consider each relevant scientific framework developed under this Act when making recommendations for exception funding for grant applications.

Congressional Research Service summary (Passed House amended), quoted unchanged (nonpartisan). Read the source.

What a vote does

A “Yea” vote

If it passes both chambers and is signed, it becomes law.

A “Nay” vote

If it is not passed, current law stays as it is.

PSI Sci description of the legislative step (not an opinion).

What does this mean? (plain words)

Official text

Recalcitrant Cancer Research Act of 2012

Source: Congressional Research Service summary (Passed House amended)

AI explanation – may be wrong, check the official text

No AI explanation yet. It takes up to a minute to write and is then saved for everyone.

Limited to a few requests an hour per person.

The strongest published arguments

Arguments for (supporters)

Needs sources: no published arguments on this side yet. We only show items backed by a published source. Suggest one.

Arguments against (opponents)

Needs sources: no published arguments on this side yet. We only show items backed by a published source. Suggest one.

Alternatives

Needs sources: no published alternatives yet (for example a different bill, a law instead of an amendment, or keeping current law). We only show items backed by a published source. Suggest one.

How did my representative vote? · This bill's floor votes

Officials and money

Sponsor: Rep. Eshoo, Anna G. [D-CA-14] · 294 cosponsors

Cost estimate: No cost estimate published yet.

Cosponsors on this site

Zoe Lofgren (D-CA), Richard E. Neal (D-MA), Jim Costa (D-CA), Janice D. Schakowsky (D-IL), Frank Pallone, Jr. (D-NJ), Adam B. Schiff (D-CA), Michael R. Turner (R-OH), Gwen Moore (D-WI), Eleanor Holmes Norton (D-DC), Diana DeGette (D-CO), Stephen F. Lynch (D-MA), James P. McGovern (D-MA), Chris Van Hollen (D-MD), Shelley Moore Capito (R-WV), Tammy Baldwin (D-WI), Rosa L. DeLauro (D-CT), Yvette D. Clarke (D-NY) and 234 more.

No linked floor roll calls in our collected records yet. This does not mean the bill has never had a vote. Check the official bill history.

Words on this page, explained (1)

Appropriation: Money a legislature sets aside by law for a specific purpose. Government agencies may spend public money only as it has been appropriated.

Plain meanings written from linked sources. All words.

Sources

Congressional Research Service summary (Passed House amended)
Congress.gov
Data: GovInfo BILLSTATUS bulk data (Library of Congress), BILLSTATUS-112hr733.xml <https://www.govinfo.gov/bulkdata/BILLSTATUS/112/hr>

Record fed-us-cong112-hr733 · catalog fed-us-congress-bills-cong112 · updated 2026-11-15 by psicol fed-bills-cong112